Altman Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.46M | Buy |
21,986
+716
| +3% | +$80K | 1% | 34 |
|
|
2025
Q1 | $2.27M | Buy |
21,270
+317
| +2% | +$33.8K | 1.04% | 28 |
|
|
2024
Q4 | $1.94M | Buy |
20,953
+78
| +0.4% | +$7.21K | 0.83% | 47 |
|
|
2024
Q3 | $1.75M | Buy |
20,875
+253
| +1% | +$21.2K | 0.78% | 62 |
|
|
2024
Q2 | $1.41M | Buy |
20,622
+554
| +3% | +$38K | 0.8% | 62 |
|
|
2024
Q1 | $1.46M | Buy |
20,068
+877
| +5% | +$63.9K | 0.71% | 72 |
|
|
2023
Q4 | $1.55M | Sell |
19,191
-132
| -0.7% | -$10.7K | 0.82% | 52 |
|
|
2023
Q3 | $1.45M | Buy |
+19,323
| New | +$1.45M | 0.9% | 39 |
|
|
2023
Q1 | $1.34M | Buy |
19,145
+364
| +2% | +$25.6K | 1.23% | 29 |
|
|
2022
Q4 | $1.64M | Sell |
18,781
-658
| -3% | -$57.4K | 1.01% | 27 |
|
|
2022
Q3 | $1.2M | Buy |
+19,439
| New | +$1.2M | 0.76% | 46 |
|
|
2020
Q4 | – | Sell |
-6,054
| Closed | -$383K | – | 85 |
|
|
2020
Q3 | $383K | Sell |
6,054
-24,723
| -80% | -$1.56M | 0.27% | 73 |
|
|
2020
Q2 | $2.37M | Sell |
30,777
-75
| -0.2% | -$5.77K | 2.01% | 18 |
|
|
2020
Q1 | $2.31M | Buy |
+30,852
| New | +$2.31M | 2.14% | 9 |
|